A prospective study of the effectiveness of mesenchymal stem cell therapy for lymphedema
Not Applicable
Recruiting
- Conditions
- ower limb lymphedema
- Registration Number
- JPRN-UMIN000032564
- Lead Sponsor
- Avenue Cell Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with active cancer, deep vein thronbosis and/or lymphedema morphologically classified into hyperplasia.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Immediate pre-intervantion and 1, 3, 6 months post intervention volume of edema Visual analogue scale (VAS) of pain Skin stiffness Adverse event:Clavien-dindo classification
- Secondary Outcome Measures
Name Time Method